Search

everythinglearnresearchcommunity

for

Search:↓

The sebaceous gland plays a significant role in hair loss and thinning, and using growth stimulators, DHT inhibitors, anti-inflammatory drugs, anti-androgens, and super oxide dismuse substances can help manage it.

There are several promising treatments for hair loss, including dutasteride, latanoprost, ketoconazole shampoo, anti-androgens, laser/light treatment, and platelet-rich plasma, but more research is needed.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Male pattern baldness is mainly caused by a hormone called dihydrotestosterone (DHT), and drugs that can block this hormone might help prevent hair loss.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Antiandrogenic treatments can effectively manage certain skin conditions by using female hormones.

Anti-androgens can help treat tough skin conditions like severe acne and excessive hair growth.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

COVID-19 may worsen hair loss, but treatments like minoxidil can help.

A new method using fat tissue cells may help treat hair loss.

Platelet-rich plasma injections are a promising new treatment for hair loss, showing initial positive results.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

The emulgel with Saw Palmetto and Sophora Japonica shows promise for treating hair loss.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Title change to "Central Centrifugal Cicatricial Alopecia (CCCA)"; common in African American women; hair-grooming methods may contribute; no effective therapy found; trials needed.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

The topical formula with sidr leaves and roasted candlenut extracts significantly boosts hair growth for alopecia.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Adalimumab can cause hair loss and scalp issues in some psoriasis patients.

The leaf extract of Leea indica may reduce inflammation, dissolve blood clots, and promote hair growth.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Early diagnosis of frontal fibrosing alopecia is crucial to prevent permanent hair loss.

The bark of Myrica rubra contains compounds that can block testosterone effects and might help prevent hair loss.